- Title
- Rucaparib maintenance in ATHENA-MONO (GOG-3020/ENGOT-ov45) in patients with newly diagnosed advanced ovarian cancer: exploratory post-progression evaluations for patients with HRD-negative and HRD-unknown tumours
- Creators
- Flora Zagouri - National and Kapodistrian University of AthensJohn Paul Diaz - Baptist Health South FloridaXing Zeng - McGill UniversityPurificación Martinez- Del Prado - Medical Oncology Department, Basurto University Hospital, Bilbao, SpainAndrea Jewell - University of Kansas Medical CenterVanda Salutari - Università Cattolica del Sacro CuoreLinda Van Le - Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, United StatesChien-Hsing Lu - Taichung Veterans General HospitalOguzhan Kuru - Department of Obstetrics and Gynecology, Cerrahpasa School of Medicine, Istanbul, TürkiyeLeslie S. Bradford - MaineHealthAnita Chudecka-Glaz - Pomeranian Medical UniversityWilliam H. Bradley - Medical College of WisconsinDearbhaile C. Collins - Cork University HospitalRobert Holloway - Department of Gynecologic Oncology, AdventHealth Cancer Institute, Orlando, United StatesJen Borrow - pharma&, New York, United StatesValerie Ong - pharma&, New York, United StatesKeiichi Fujiwara - Saitama Medical UniversityRebecca S. Kristeleit - Guy's and St Thomas' NHS Foundation TrustBradley J. Monk - Florida Cancer Specialists & Research Institute
- Publication Details
- International journal of gynecological cancer, Vol.36(2), p.103090
- Publisher
- Elsevier Inc
- Identifiers
- 991006256541202656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Rucaparib maintenance in ATHENA-MONO (GOG-3020/ENGOT-ov45) in patients with newly diagnosed advanced ovarian cancer: exploratory post-progression evaluations for patients with HRD-negative and HRD-unknown tumours
International journal of gynecological cancer, Vol.36(2), p.103090
02/2026
Metrics
1 Record Views